Impact and relationship of anterior commissure and time-dose factor on the local control of T1N0 glottic cancer treated by 6 MV photons

Radiation Oncology

Volumn 6, Issue 1, 2011, Pages

  Tong, Chi Chung ^a   Au, Kwok Hung ^a   Ngan, Roger K C ^a   Chow, Sin Ming ^a   Cheung, Foon Yiu ^a   Fu, Yiu Tung ^a   Au, Joseph S K ^a   Law, Stephen C K ^a  

^a QUEEN ELIZABETH HOSPITAL   (Hong Kong)

Author keywords

6 MV; Anterior commissure; Biologically effective dose; Radiotherapy; T1N0 glottic cancer

Indexed keywords

ADULT; ANTERIOR COMMISSURE; ARTICLE; BEDTIME DOSAGE; CANCER CONTROL; CANCER STAGING; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INSTITUTIONAL CARE; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIVARIATE ANALYSIS; PHOTON; RADIATION DOSE FRACTIONATION; RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; GLOTTIS; LARYNX TUMOR; METHODOLOGY; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RADIATION DOSE; RADIATION EXPOSURE; RADIATION RESPONSE; RADIOMETRY; RETROSPECTIVE STUDY;

DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FOLLOW-UP STUDIES; GLOTTIS; HUMANS; LARYNGEAL NEOPLASMS; MALE; MULTIVARIATE ANALYSIS; PHOTONS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RADIATION DOSAGE; RADIOMETRY; RADIOTHERAPY; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79956226155     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-6-53     Document Type: Article

References (47)

1. Hospital Authority Hong Kong Cancer Registry web site. Hospital Authority., http://www.3.ha.org.hk/cancereg/e_stat.asp
2. Wei W. Management of early carcinoma of the larynx: the Asian perspective. ENT News 2000, 9:18-19.
3. Mendenhall WM, Amdur RJ, Morris CG, et al. T1-T2N0 Squamous Cell Carcinoma of the Glottic Larynx Treated With Radiation Therapy. J Clin Oncol 2001, 19:4029-4036.
4. Cellai E, Frata P, Magrini SM, et al. Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. I. The case of T1N0 disease. International Journal of Radiation Oncology Biology Physics 2005, 63:1378-1386.
5. Warde P, O'Sullivan B, Bristow RG, et al. T1/T2 Glottic Cancer Managed by External Beam Radiotherapy: The Influence of Pretreatment Hemoglobin on Local Control. International Journal of Radiation Oncology, Biology, Physics 1998, 41:347-353. 10.1016/S0360-3016(98)00062-5, 9607350.
6. Foote RL, Grado GL, Buskirk SJ, et al. Radiation therapy for glottic cancer using 6-MV photons. Cancer 1996, 77:381-386. 10.1002/(SICI)1097-0142(19960115)77:2<381::AID-CNCR22>3.0.CO;2-X, 8625248.
7. Akine Y, Tokita N, Ogino T, et al. Radiotherapy of T1 glottic cancer with 6 MeV X rays. International Journal of Radiation Oncology Biology Physics 1991, 20:1215-1218.
8. Izuno I, Sone S, Oguchi M, et al. Treatment of early vocal cord carcinoma with 60 Co gamma rays, 8/10 MV X-rays, or 4 MV X-rays -- are the results different ?. Acta Oncol 1990, 29:637-639. 10.3109/02841869009090067, 2206580.
9. Devineni VR, King K, Perez C. Early glottic carcinoma treated with radiotherapy: impact of treatment energy on sucess rate. International Journal of Radiation Oncology Biology Physics 1992, 24:106.
10. Sobin LH, Wittekind CH. UICC TNM Classification of malignant tumours. 2002, New York.: John Wiley & Sons, 6.
11. Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. British Journal of Radiology 1989, 62:679-694. 10.1259/0007-1285-62-740-679, 2670032.
12. Robertson AG, Robertson C, Boyle P, et al. The effect of differing radiotherapyeutic schedules on the response of glottic carcinoma of the larynx. Eur J Cancer 1993, 29A:501-510.
13. Skladowski K, Law MG, Maciejewski B, et al. Planned and unplanned gaps in radiotherapy: The importance of gap position and gap duration. Radiotherapy and Oncology 1994, 30:109-120. 10.1016/0167-8140(94)90039-6, 8184108.
14. Fowler JF. 21 years of Biologically Effective Dose. Br J Radiol 2010, 83:554-568. 10.1259/bjr/31372149, 20603408.
15. Trotti A, Colevas AD, Setser A, et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Seminars in Radiation Oncology 2003, 13:176-181. 10.1016/S1053-4296(03)00031-6, 12903007.
16. Pfister DG, Laurie SA, Weinstein GS, et al. American Society of Clinical Oncology Clinical Practice Guideline for the Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer. J Clin Oncol 2006, 24:3693-3704. 10.1200/JCO.2006.07.4559, 16832122.
17. Kaanders JH, Hordijk GJ. Carcinoma of the larynx: the Dutch national guideline for diagnostics, treatment, supportive care and rehabilitation. Radiotherapy and Oncology 2002, 63:299-307. 10.1016/S0167-8140(02)00073-7, 12142094.
18. Steiner W. Results of curative laser microsurgery of laryngeal carcinomas. American Journal of Otolaryngology 1993, 14:116-121. 10.1016/0196-0709(93)90050-H, 8484476.
19. Jing J, Zhongxing L, Li G, et al. Analysis of prognostic factors for T1N0M0 glottic cancer treated with definitive radiotherapy alone: experience of the cancer hospital of Peking Union Medical College and the Chinese Academy Of Medical Sciences. International Journal of Radiation Oncology, Biology, Physics 2002, 54:471-478. 10.1016/S0360-3016(02)02920-6, 12243824.
20. Franchin G, Minatel E, Gobitti C, et al. Radiotherapy for patients with early-stage glottic carcinoma. Cancer 2003, 98:765-772. 10.1002/cncr.11575, 12910521.
21. Le Q-TX, Fu KK, Kroll S, et al. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma. International Journal of Radiation Oncology Biology Physics 1997, 39:115-126.
22. Yu E, Shenouda G, Beaudet MP, et al. Impact of radiation therapy fraction size on local control of early glottic carcinoma. International Journal of Radiation Oncology Biology Physics 1997, 37:587-591.
23. Johansen LV, Grau C, Overgaard J. Glottic carcinoma - patterns of failure and salvage treatment after curative radiotherapy in 861 consecutive patients. Radiotherapy and Oncology 2002, 63:257-267. 10.1016/S0167-8140(02)00118-4, 12142089.
24. Yamazaki H, Nishiyama K, Tanaka E, et al. Radiotherapy for early glottic carcinoma (T1N0M0): Results of prospective randomized study of radiation fraction size and overall treatment time. International Journal of Radiation Oncology Biology Physics 2006, 64:77-82.
25. Reddy SP, Mohideen N, Marra S, et al. Effect of tumor bulk on local control and survival of patients with T1 glottic cancer. Radiotherapy and oncology 1998, 47:161-166. 10.1016/S0167-8140(97)00196-5, 9683364.
26. Johansen LV, Grau C, Overgaard J. Laryngeal Carcinoma - multivariate analysis of prognostic factors in 1252 consecutive patients treated with primary radiotherapy. Acta Oncologica 2003, 42:771-778. 10.1080/02841860310017595, 14690164.
27. Fein DA, Lee WR, Hanlon AL, et al. Do overall treatment time, field size, and treatment energy influence local control of T1-T2 squamous cell carcinomas of the glottic larynx?. International Journal of Radiation Oncology Biology Physics 1996, 34:823-831.
28. Lee JH, Machtay M, McKenna MG, et al. Radiotherapy with 6-megavolt photons for early glottic carcinoma: Potential impact of extension to the posterior vocal cord. American Journal of Otolaryngology 2001, 22:43-54. 10.1053/ajot.2001.20679, 11172214.
29. Marshak G, Brenner B, Shvero J, et al. Prognostic factors for local control of early glottic cancer: the Rabin Medical Center retrospective study on 207 patients. International Journal of Radiation Oncology Biology Physics 1999, 43:1009-1013.
30. Smee RI, Meagher NS, Williams JR, et al. Role of radiotherapy in early glottic carcinoma. Head & Neck 2010, 32:850-859.
31. Sessions DG, Ogura JH, Fried MP. The anterior commissure in glottic carcinoma. Laryngoscope 1975, 85:1624-1632. 10.1288/00005537-197510000-00002, 1186392.
32. Epp ER, Boyer AL, Doppke KP. Underdosing of lesions resulting from lack of electronic equilibrium in upper respiratory air cavities irradiated by 10 MV X- ray beams. International Journal of Radiation Oncology Biology Physics 1977, 2:613-619.
33. Klein EE, Chin LM, Rice RK, et al. The influence of air cavities on interface doses for photon beams. International Journal of Radiation Oncology Biology Physics 1993, 27:419-427.
34. Sombeck MD, Kalbaugh KJ, Mendenhall WM, et al. Radiotherapy for early vocal cord cancer: A dosimetric analysis of CO-60 versus 6 MV photons. Head & Neck 1996, 18:167-173. 10.1002/(SICI)1097-0347(199603/04)18:2<167::AID-HED9>3.0.CO;2-#, 21608136.
35. Spirydovich S, Papiez L, Moskvin V, et al. Evaluation of underdosage in the external photon beam radiotherapy of glottic carcinoma: Monte Carlo study. Radiotherapy and Oncology 2006, 78:159-164. 10.1016/j.radonc.2005.11.010, 16360226.
36. Gowda RV, Henk JM, Mais KL, et al. Three weeks radiotherapy for T1 glottic cancer: the Christie and Royal Marsden Hospital Experience. Radiotherapy and Oncology 2003, 68:105-111. 10.1016/S0167-8140(03)00059-8, 12972304.
37. Sjögren EV, Wiggenraad RG, Le Cessie S, et al. Outcome of radiotherapy in T1 glottic carcinoma: a population-based study. European Archives of Oto-Rhino-Laryngology 2009, 266:735-744. 10.1007/s00405-008-0803-9, 18839197.
38. Kim RY, Marks ME, Salter MM. Early-stage glottic cancer: importance of dose fractionation in radiation therapy. Radiology 1992, 182:273-275.
39. Mendenhall WM, Parsons JT, Million RR, et al. T1-T2 squamous cell carcinoma of the glottic larynx treated with radiation therapy: relationship of dose-fractionation factors to local control and complications. International Journal of Radiation Oncology Biology Physics 1988, 15:1267-1273.
40. NCCN Practice Guidelines in Oncology- v.2.2010 NCCN Practice Guidelines in Oncology- v.2.2010., http://www.nccn.org
41. Skladowski K, Tarnawski R, Maciejewski B, et al. Clinical radiobiology of glottic T1 squamous cell carcinoma. International Journal of Radiation Oncology Biology Physics 1999, 43:101-106.
42. van der Voet JC, Keus RB, Hart AA, et al. The impact of treatment time and smoking on local control and complications in T1 glottic cancer. International Journal of Radiation Oncology Biology Physics 1998, 42:247-255.
43. Fowler JF. Fractionation and glottic carcinoma. International Journal of Radiation Oncology Biology Physics 1997, 39:1-2.
44. Overgaard J, Hansen HS, Specht L, et al. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial. The Lancet 2003, 362:933-940.
45. Overgaard J, Mohanti BK, Begum N, et al. Five versus six fractions of radiotherapy per week for squamous-cell carcinoma of the head and neck (IAEA-ACC study): a randomised, multicentre trial. The Lancet Oncology 2010, 11:553-560. 10.1016/S1470-2045(10)70072-3, 20382075.
46. Fowler JF, Harari PM, Leborgne F, et al. Acute radiation reactions in oral and pharyngeal mucosa: tolerable levels in altered fractionation schedules. Radiotherapy and Oncology 2003, 69:161-168. 10.1016/S0167-8140(03)00231-7, 14643953.
47. Rucci L, Gammarota L, Gallo O. Carcinoma of the anterior commissure of the larynx. II. Proposal of a new staging system. The Annals of Otology Rhinol Laryngol 1996, 105:391-396.